Growth remains soft while we wait for new releases. EBIT ests. down, but we maintain the FCF ests. 13% FCF yield on '24e, SEK 215m net cash end of '23.
Sales in line, write-down of advances weighed on EBIT, FCF solid. We cut '23e-'25e adj. EBIT by 3-5% on slightly higher costs. Trading at 7.2x-5.1x EV/EBIT and 12-14% FCF yield on '23e-'25e.
Q1 due 4 May; trends continue to look positive with HC stabilising and Sherlock growing. The share is trading at 8x EV/EBIT 2023e, with an 8% FCF yield.